Speciality Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Education Dialogues
    • Business Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Speciality Medical Dialogues
    • Editorial
    • News
        • Anesthesiology
        • Cancer
        • Cardiac Sciences
        • Critical Care
        • Dentistry
        • Dermatology
        • Diabetes and Endo
        • Diagnostics
        • ENT
        • Featured Research
        • Gastroenterology
        • Geriatrics
        • Medicine
        • Nephrology
        • Neurosciences
        • Nursing
        • Obs and Gynae
        • Ophthalmology
        • Orthopaedics
        • Paediatrics
        • Parmedics
        • Pharmacy
        • Psychiatry
        • Pulmonology
        • Radiology
        • Surgery
        • Urology
    • Practice Guidelines
        • Anesthesiology Guidelines
        • Cancer Guidelines
        • Cardiac Sciences Guidelines
        • Critical Care Guidelines
        • Dentistry Guidelines
        • Dermatology Guidelines
        • Diabetes and Endo Guidelines
        • Diagnostics Guidelines
        • ENT Guidelines
        • Featured Practice Guidelines
        • Gastroenterology Guidelines
        • Geriatrics Guidelines
        • Medicine Guidelines
        • Nephrology Guidelines
        • Neurosciences Guidelines
        • Obs and Gynae Guidelines
        • Ophthalmology Guidelines
        • Orthopaedics Guidelines
        • Paediatrics Guidelines
        • Psychiatry Guidelines
        • Pulmonology Guidelines
        • Radiology Guidelines
        • Surgery Guidelines
        • Urology Guidelines
    LoginRegister
    Speciality Medical Dialogues
    LoginRegister
    • Home
    • Editorial
    • News
      • Anesthesiology
      • Cancer
      • Cardiac Sciences
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endo
      • Diagnostics
      • ENT
      • Featured Research
      • Gastroenterology
      • Geriatrics
      • Medicine
      • Nephrology
      • Neurosciences
      • Nursing
      • Obs and Gynae
      • Ophthalmology
      • Orthopaedics
      • Paediatrics
      • Parmedics
      • Pharmacy
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
    • Practice Guidelines
      • Anesthesiology Guidelines
      • Cancer Guidelines
      • Cardiac Sciences Guidelines
      • Critical Care Guidelines
      • Dentistry Guidelines
      • Dermatology Guidelines
      • Diabetes and Endo Guidelines
      • Diagnostics Guidelines
      • ENT Guidelines
      • Featured Practice Guidelines
      • Gastroenterology Guidelines
      • Geriatrics Guidelines
      • Medicine Guidelines
      • Nephrology Guidelines
      • Neurosciences Guidelines
      • Obs and Gynae Guidelines
      • Ophthalmology Guidelines
      • Orthopaedics Guidelines
      • Paediatrics Guidelines
      • Psychiatry Guidelines
      • Pulmonology Guidelines
      • Radiology Guidelines
      • Surgery Guidelines
      • Urology Guidelines
    • Home
    • News
    • Cardiac Sciences
    • Elevated cardiac...

    Elevated cardiac troponin no benign condition even in absence of MI

    Written by Medha Baranwal Baranwal Published On 2019-01-11T19:20:57+05:30  |  Updated On 11 Jan 2019 7:20 PM IST
    Elevated cardiac troponin no benign condition even in absence of MI

    Cardiac troponin (cTn) elevation without a clear aetiology is no benign condition for patients with chest pain, according to a new study. The study, published in the Journal of the American College of Cardiology, suggests that the finding of myocardial injury should be followed by careful workup in these patients.


    Elevated cTn levels is a common finding in acutely admitted patients, even in the absence of acute coronary syndrome. In some of these patients, no etiology of cTn elevation can be identified. The term troponinemia is sometimes used to describe this scenario.


    Kai M. Eggers, Uppsala University in Sweden, and colleagues aimed to investigate the associations of cTn levels with clinical findings and long-term outcome in acutely admitted patients with the suspected acute coronary syndrome who had been discharged without a specified diagnosis.


    In this retrospective registry-based cohort study investigating 48,872 patients from the SWEDEHEART registry (Swedish Web-system for Enhancement and Development of Evidence-based care in Heart disease Evaluated According to Recommended Therapies). Patients were stratified into cohorts with cTn levels less than or equal to the assay-specific 99th percentile and separated by assay-specific cTn tertiles in case of higher levels.


    Also Read: Any Detectable Cardiac Troponin T even without MI linked to adverse outcomes

    Key Findings:

    • Over a median 4.9 years of follow-up in the SWEDEHEART registry, one in three of those in the highest cTn tertile above the 99th percentile indicative of myocardial injury but who were discharged without a diagnosis of a cardiac event later died had an MI or stroke or were admitted for heart failure. This group significantly exceeded the normal troponin group in risk (HR 2.59, 95% CI 2.39-2.80).

    • In the SWEDEHEART registry, one in five people admitted acutely for a suspected ACS had cTn levels exceeding the 99th percentile.

    • Even the "healthiest" patients in that high cTn group -- those without cardiovascular comorbidities, renal dysfunction, left ventricular dysfunction, or significant coronary stenosis -- showed increased odds of major events

    • Their risk of major adverse events (all-cause mortality, MI, heart failure readmission, or stroke) climbed in a stepwise fashion when further divided into tertiles by cTn compared with people below the 99th percentile, whose rate of events was 271.5 per 10,000 patient-years:

      • Tertile 1 (lower cTn): 419.1 per 10,000 patient-years

      • Tertile 2: 562.4 per 10,000 patient-years

      • Tertile 3 (highest cTn): 1,046.1 per 10,000 patient-years




    Also Read: Elevated cardiac troponin may occur without heart attack: Latest JACC Study

    "Our data are in line with results from studies investigating cTn levels in other populations without acute cardiovascular disease," the researchers wrote. "A common denominator of these studies is the mediation of the prognostic importance of cTn through its association with cardiac abnormalities. These might possibly still be subclinical at the time point of cTn measurement."


    "Troponinemia" has been used to describe elevated cTn with no clear reason, but it is "trivializing and should be avoided," the investigators argued.


    The next steps after finding abnormal troponin could include a cTn retest (perhaps using a different assay), referral for echocardiography, and invasive or noninvasive coronary imaging, depending on the person's pre-test probability of coronary artery disease, said the research team.


    "cTn elevation is associated with cardiovascular and noncardiovascular comorbidities and predicts major adverse events in acutely admitted patients, in whom no definite diagnosis could have been established," the authors concluded, adding that, "the term troponinemia is trivializing and should be avoided. Instead, careful work-up is required in these patients."


    For further reference log on to 10.1016/j.jacc.2018.09.082
    CADcardiac troponinchest painCoronary artery diseasecTncTn levelsDiagnosisheart failureheart injuryheart-attackJournal of the American College of CardiologyKai EggersMImyocardial injurystrokeSWEDEHEARTtroponinemia
    Source : With inputs from Journal of the American College of Cardiology

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Medha Baranwal Baranwal
    Medha Baranwal Baranwal
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 12 Oct 2022 7:06 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok